Explore our latest eReport: 3D biology and organoids
Organoids and 3D biology are revolutionising drug discovery, offering more physiologically relevant models to study diseases, screen compounds, and develop personalised treatments. These technologies provide deeper insights into human biology, bridging the gap between in vitro research and clinical success.
In 2024, the field has seen significant advancements, addressing previous challenges related to scalability, reproducibility, and translational potential.
This In Focus eReport highlights the latest breakthroughs shaping the future of drug discovery in this area.
The eReport includes:
- A global market overview of organoids and 3D biology
- Unlocking the potential of CNS organoid models: an article in which Dr Bryan Vought shares his thoughts
- Insight from SPT Labtech on how automation is advancing organoid and 3D biology models
- New frontiers for organoids and 3D biology
